CanBas Co., Ltd. (4575.T)
JPY 907.0
(-1.2%)
JPY 907.0
(-1.2%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -67.87 JPY | 18.26% |
| 2022 | -83.03 JPY | 5.99% |
| 2021 | -88.32 JPY | -26.14% |
| 2020 | -70.02 JPY | 16.28% |
| 2019 | -83.64 JPY | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 Q4 | -36.81 JPY | -300.54% |
| 2023 Q1 | -11.19 JPY | 66.32% |
| 2023 FY | - JPY | 18.22% |
| 2023 Q3 | -9.19 JPY | 17.8% |
| 2023 Q2 | -11.18 JPY | 0.09% |
| 2022 Q2 | -15.84 JPY | 36.69% |
| 2022 FY | - JPY | 5.99% |
| 2022 Q4 | -33.22 JPY | -254.54% |
| 2022 Q3 | -9.37 JPY | 40.85% |
| 2022 Q1 | -25.02 JPY | 0.0% |
| 2021 FY | - JPY | -26.14% |
| 2020 FY | - JPY | 16.28% |
| 2019 FY | - JPY | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 92.20 JPY | 173.612% |
| PRISM BioLab Co.,LTD | -14.90 JPY | -355.503% |
| GNI Group Ltd. | 169.50 JPY | 140.041% |
| Linical Co., Ltd. | 14.98 JPY | 553.071% |
| Trans Genic Inc. | 0.24 JPY | 28379.167% |
| MEDINET Co., Ltd. | -6.65 JPY | -920.602% |
| Soiken Holdings Inc. | -25.32 JPY | -168.049% |
| Cytori Cell Research Institute, Inc. | 15.47 JPY | 538.72% |
| AnGes, Inc. | -39.29 JPY | -72.741% |
| OncoTherapy Science, Inc. | -6.05 JPY | -1021.818% |
| Nxera Pharma Co., Ltd. | -87.17 JPY | 22.141% |
| Immuno-Biological Laboratories Co., Ltd. | 20.05 JPY | 438.504% |
| NanoCarrier Co., Ltd. | -11.10 JPY | -511.441% |
| Carna Biosciences, Inc. | -68.62 JPY | 1.093% |
| D. Western Therapeutics Institute, Inc. | -25.56 JPY | -165.532% |
| RaQualia Pharma Inc. | -14.98 JPY | -353.071% |
| Chiome Bioscience Inc. | -24.62 JPY | -175.67% |
| Kidswell Bio Corporation | -40.23 JPY | -68.705% |
| PeptiDream Inc. | 23.41 JPY | 389.919% |
| Oncolys BioPharma Inc. | -108.92 JPY | 37.688% |
| Ribomic Inc. | -28.70 JPY | -136.481% |
| SanBio Company Limited | -40.48 JPY | -67.663% |
| Healios K.K. | -56.22 JPY | -20.722% |
| BrightPath Biotherapeutics Co., Ltd. | -18.21 JPY | -272.707% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -26.79 JPY | -153.341% |
| Delta-Fly Pharma, Inc. | -198.72 JPY | 65.846% |
| StemRIM | -32.98 JPY | -105.791% |
| CellSource Co., Ltd. | 48.88 JPY | 238.85% |
| FunPep Company Limited | -39.63 JPY | -71.259% |
| Kringle Pharma, Inc. | -158.46 JPY | 57.169% |
| Stella Pharma Corporation | -24.66 JPY | -175.223% |
| TMS Co., Ltd. | -26.02 JPY | -160.838% |
| Noile-Immune Biotech Inc. | -27.25 JPY | -149.064% |
| Cuorips Inc. | -85.87 JPY | 20.962% |
| K Pharma,Inc. | 22.43 JPY | 402.586% |
| Takara Bio Inc. | 12.29 JPY | 652.238% |
| ReproCELL Incorporated | -0.37 JPY | -18243.243% |
| PhoenixBio Co., Ltd. | 6.88 JPY | 1086.483% |
| StemCell Institute Inc. | 30.25 JPY | 324.364% |
| Japan Tissue Engineering Co., Ltd. | 3.53 JPY | 2022.663% |
| CellSeed Inc. | -29.43 JPY | -130.615% |